Disease Landscape and Forecast Insights

Clarivate Epidemiology’s coverage of atopic dermatitis/atopic eczema (AD) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United…

Clarivate Epidemiology’s coverage of alzheimer’s disease comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the diagnosed events of alzheimer’s…

Clarivate Epidemiology’s coverage of atopic dermatitis (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of AD for each…

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key AD patient populations, covering 171 countries and more than 99% of…

Clarivate Epidemiology’s coverage of atopic dermatitis (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of AD for each…

Clarivate Epidemiology’s coverage of atopic dermatitis (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of AD for each…

Clarivate Epidemiology’s coverage of atopic dermatitis (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of AD for each…

Clarivate Epidemiology’s coverage of Alzheimer’s disease (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the lifetime prevalence of AD…

Clarivate Epidemiology’s coverage of atopic dermatitis (AD) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of AD for each…

The addition of immune checkpoint inhibitors to the renal cell carcinoma armamentarium has significantly changed the treatment of this disease. In 2021, Keytruda (Merck & Co.) became the first…

First-line treatment of chronic heart failure (CHF) usually involves an angiotensin-converting enzyme (ACE) inhibitor, an oral beta blocker, or an oral diuretic. The addition of a second- or third-…

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder associated with progressive inflammation and/or fibrosis of the lung tissue. The leading cause of the disorder is unknown. Individuals…